Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $757.70 | 53 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $409.25 | 30 | $0 (2019) |
| GlaxoSmithKline, LLC. | $113.16 | 8 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $47.67 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $36.91 | 3 | $0 (2018) |
| PFIZER INC. | $35.26 | 2 | $0 (2024) |
| Amgen Inc. | $27.89 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.77 | 2 | $0 (2018) |
| Novo Nordisk Inc | $22.93 | 2 | $0 (2019) |
| Circassia Pharmaceuticals Inc | $16.78 | 1 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $12.39 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $72.08 | 3 | Regeneron Healthcare Solutions, Inc. ($47.67) |
| 2019 | $105.63 | 8 | Janssen Pharmaceuticals, Inc ($94.28) |
| 2018 | $306.33 | 22 | Janssen Pharmaceuticals, Inc ($172.57) |
| 2017 | $273.66 | 20 | Janssen Pharmaceuticals, Inc ($142.40) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: PAIN | ||||||
| 11/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/09/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/30/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/25/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/15/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Diabetes | ||||||
| 04/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/19/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/05/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/14/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/13/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/12/2018 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/01/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $12.65 | General |
| 09/10/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/24/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE, PRAXBIND | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/20/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/02/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $12.98 | General |
| 07/16/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/25/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/20/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: RESPIRATORY | ||||||
| 05/03/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/17/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/30/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 76 | 142 | $58,800 | $11,607 |
| 2022 | 7 | 182 | 317 | $96,233 | $19,167 |
| 2021 | 8 | 197 | 310 | $110,915 | $23,846 |
| 2020 | 9 | 201 | 362 | $110,519 | $24,012 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 59 | $25,252 | $5,505 | 21.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 40 | $11,920 | $2,253 | 18.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 17 | $13,906 | $2,198 | 15.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 22 | 26 | $7,722 | $1,651 | 21.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 30 | 108 | $29,268 | $5,878 | 20.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 40 | 86 | $24,854 | $4,705 | 18.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 28 | 30 | $16,080 | $2,847 | 17.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 36 | 39 | $11,232 | $2,154 | 19.2% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 14 | 15 | $7,665 | $1,543 | 20.1% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2022 | 17 | 18 | $5,202 | $1,040 | 20.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 17 | 21 | $1,932 | $1,000 | 51.8% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 28 | 74 | $25,789 | $5,530 | 21.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 41 | 78 | $21,840 | $4,691 | 21.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 22 | 22 | $16,946 | $3,813 | 22.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 27 | 37 | $14,902 | $3,230 | 21.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 31 | 32 | $8,944 | $1,967 | 22.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 18 | $9,365 | $1,878 | 20.1% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 14 | 33 | $8,654 | $1,839 | 21.3% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2021 | 16 | 16 | $4,476 | $898.68 | 20.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 46 | 98 | $26,632 | $5,468 | 20.5% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 26 | 75 | $19,088 | $4,228 | 22.2% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 19 | 50 | $16,913 | $3,753 | 22.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 18 | 19 | $14,207 | $2,752 | 19.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 35 | 39 | $10,579 | $2,304 | 21.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 15 | 15 | $7,575 | $1,710 | 22.6% |
About Dr. Gary Candelaria, D.O
Dr. Gary Candelaria, D.O is a Family Medicine healthcare provider based in Colfax, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972583722.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Candelaria, D.O has received a total of $757.70 in payments from pharmaceutical and medical device companies, with $72.08 received in 2024. These payments were reported across 53 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($757.70).
As a Medicare-enrolled provider, Candelaria has provided services to 656 Medicare beneficiaries, totaling 1,131 services with total Medicare billing of $78,632. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Colfax, WA
- Active Since 01/18/2006
- Last Updated 10/14/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1972583722
Products in Payments
- XARELTO (Drug) $282.56
- INVOKANA (Drug) $126.69
- BREO (Drug) $50.14
- DUPIXENT (Biological) $47.67
- TRELEGY ELLIPTA (Drug) $36.96
- NURTEC ODT (Drug) $24.41
- TUDORZA PRESSAIR (Drug) $16.78
- ANORO (Drug) $13.40
- JARDIANCE (Drug) $12.67
- Amitiza (Drug) $12.39
- SOLIQUA (Drug) $11.69
- Victoza (Drug) $11.58
- Ozempic (Drug) $11.35
- AIMOVIG (Biological) $11.28
- PRADAXA (Drug) $11.10
- LYRICA (Drug) $10.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Colfax
Mark Parsons, Md, MD
Family Medicine — Payments: $3,931
Dr. William Mellor, M.d, M.D
Family Medicine — Payments: $3,737
Govind Singh, M.d, M.D
Family Medicine — Payments: $2,966
Anthony Lundberg, Do, DO
Family Medicine — Payments: $486.84
Sarah Fielding, Md, MD
Family Medicine — Payments: $125.78
Dr. Brent Conrad, Md, MD
Family Medicine — Payments: $42.37